10/8
08:45 am
gri
GRI Bio, Inc. (NASDAQ: GRI) is now covered by analysts at Ascendiant Capital Markets. They set a "buy" rating and a $12.00 price target on the stock.
Medium
Report
GRI Bio, Inc. (NASDAQ: GRI) is now covered by analysts at Ascendiant Capital Markets. They set a "buy" rating and a $12.00 price target on the stock.
10/8
05:27 am
gri
Rating for GRI
High
Report
Rating for GRI